AN UNBIASED VIEW OF RETATRUTIDE

Semaglutide has been shown to result in medullary thyroid cell carcinoma in rodents. Although its clinical relevance to humans is mysterious, the FDA advises never to administer this drug in Those people with a personal or spouse and children record of medullary thyroid carcinoma. Semaglutide also poses a threat of pancreatitis and dehydration.This